MedTrace Logo

The Efficacy of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development

NCT02708628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-10-04

No results posted yet for this study

Summary

To investigate the efficacy of prophylactic use of a topical gel containing extract of allium cepae, allantoin and heparin after surgical removal of the primary cesarean scar in the second cesarean section.

Conditions

  • Cicatrix

Interventions

DRUG

extract of allium cepae, allantoin and heparin

prophylactic use of a topical gel containing extract of allium cepae, allantoin and heparin two times in a day after second c-section

PROCEDURE

Scar excision

Scar excision in second c-section

Sponsors & Collaborators

  • Suleymaniye Birth And Women's Health Education And Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Ali Galip Zebitay, M.D. · Suleymaniye Birth And Women's Health Education And Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-04-30
Completion
2016-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708628 on ClinicalTrials.gov